Page last updated: 2024-08-21

streptogramin b and quinupristin-dalfopristin

streptogramin b has been researched along with quinupristin-dalfopristin in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (66.67)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chau, F; Fantin, B; Garry, L; Leclercq, R; Lefort, A; Pavie, J; Zarrouk, V1
Canales, M; Capilla, S; Cerdá Zolezzi, P; Durán, E; Gómez-Lus, R; Goñi, P; Millán, L; Rubio Calvo, MC1
Champney, WS; Mabe, S1
Janata, J; Novotná, G; Spízek, J1
Cate, JH; Giacobbe, RA; Huang, J; Noeske, J; Olivier, NB; Zambrowski, M1
Avlami, A; Evangelopoulos, A; Hadjisoteriou, M; Petrikkos, G; Vallianou, N1

Other Studies

6 other study(ies) available for streptogramin b and quinupristin-dalfopristin

ArticleYear
Efficacies of quinupristin-dalfopristin combined with vancomycin in vitro and in experimental endocarditis due to methicillin-resistant Staphylococcus aureus in relation to cross-resistance to macrolides, lincosamides, and streptogramin B- type antibiotic
    Antimicrobial agents and chemotherapy, 2002, Volume: 46, Issue:9

    Topics: Animals; Anti-Bacterial Agents; Culture Media; Drug Resistance; Drug Therapy, Combination; Endocarditis, Bacterial; Lincosamides; Macrolides; Methicillin Resistance; Microbial Sensitivity Tests; Rabbits; Staphylococcus aureus; Streptogramin B; Time Factors; Vancomycin; Virginiamycin

2002
Macrolide resistance phenotypes of commensal viridans group streptococci and Gemella spp. and PCR detection of resistance genes.
    International journal of antimicrobial agents, 2004, Volume: 23, Issue:6

    Topics: Acetamides; Anti-Bacterial Agents; Bacterial Proteins; Drug Resistance; Erythromycin; Genes, Bacterial; Humans; Ketolides; Lincosamides; Linezolid; Macrolides; Membrane Proteins; Methyltransferases; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcaceae; Streptogramin B; Tetracycline Resistance; Virginiamycin; Viridans Streptococci

2004
A comparison of a new oral streptogramin XRP 2868 with quinupristin-dalfopristin against antibiotic-resistant strains of haemophilus influenzae, Staphylococcus aureus, and Streptococcus pneumoniae.
    Current microbiology, 2005, Volume: 51, Issue:6

    Topics: Anti-Bacterial Agents; Bacterial Proteins; Drug Combinations; Drug Resistance, Bacterial; Haemophilus influenzae; Ribosomes; Staphylococcus aureus; Streptococcus pneumoniae; Streptogramin A; Streptogramin B; Virginiamycin

2005
In vitro activity of telithromycin and quinupristin/dalfopristin against methicillin-resistant coagulase-negative staphylococci with defined resistance genotypes.
    Folia microbiologica, 2007, Volume: 52, Issue:6

    Topics: Anti-Bacterial Agents; Clindamycin; Coagulase; Drug Resistance, Bacterial; Erythromycin; Ketolides; Macrolides; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus; Streptogramin A; Streptogramin B; Virginiamycin

2007
Synergy of streptogramin antibiotics occurs independently of their effects on translation.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:9

    Topics: Anti-Bacterial Agents; Crystallography, X-Ray; Drug Combinations; Drug Synergism; Enterococcus faecalis; Escherichia coli; Haemophilus influenzae; Microbial Sensitivity Tests; Protein Biosynthesis; Ribosomes; Staphylococcus aureus; Streptococcus pneumoniae; Streptogramin A; Streptogramin B; Streptogramins; Virginiamycin

2014
Prevalence of macrolide, lincosamide, and streptogramin resistance among staphylococci in a tertiary care hospital in Athens, Greece.
    Journal of chemotherapy (Florence, Italy), 2015, Volume: 27, Issue:6

    Topics: Anti-Bacterial Agents; Clindamycin; Cross Infection; Disk Diffusion Antimicrobial Tests; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Erythromycin; Genes, Bacterial; Genotype; Greece; Hospitals, University; Humans; Microbial Sensitivity Tests; Prevalence; Staphylococcal Infections; Staphylococcus aureus; Streptogramin B; Tertiary Healthcare; Virginiamycin

2015